undamentalytics Newsletter

Ronald C Elkins: insider trades

Director at Artivion, Inc. No open-market purchases and 18 sales not made under a pre-set plan, reported from November 15, 2010 to September 6, 2018.

What happened after Ronald C Elkins’s sales?

After their sales, the shares moved +5.0% against the index over 12 months on average (a negative figure means selling was the right call); 38% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Ronald C Elkins: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 16 +5.5% +6.1% 44% 8 0.34 0.74 No reliable evidence
Sales, 12 months after the report 16 +5.0% +1.7% 38% 8 1.02 0.34 No reliable evidence
Sales, 12 months after the trade 16 +3.9% +1.2% 38% 8 0.91 0.39 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Artivion, Inc. AORT —018November 15, 2010September 6, 2018

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
September 6, 2018September 5, 2018 AORT Sale $172,650 −9.0%−26.3%−28.2%
August 13, 2018August 10, 2018 AORT Sale $38,394 −4.3%−21.3%−25.9%
June 15, 2018June 14, 2018 AORT Sale $144,450 +10.2%−1.7%−5.0%
June 1, 2018May 30, 2018 AORT Sale $81,540 +19.9%+1.0%+1.6%
May 15, 2018May 14, 2018 AORT Sale $247,500 +19.5%+5.8%+14.4%
May 10, 2018May 8, 2018 AORT Sale $173,874 +26.1%+12.8%+12.3%
November 8, 2017November 6, 2017 AORT Sale $19,030 −11.5%+55.1%+55.7%
March 9, 2016March 7, 2016 AORT Sale $22,360 +4.0%+29.1%+21.6%
November 6, 2014November 5, 2014 AORT Sale $40,320 +10.3%+4.1%+0.8%
July 31, 2014July 29, 2014 AORT Sale $24,175 −1.2%+1.9%+0.8%
August 14, 2013August 5, 2013 AORT Sale $14,040 +44.5%+35.9%+25.6%
June 3, 2013May 31, 2013 AORT Sale $13,838 −3.0%+21.2%+20.7%
August 28, 2012August 27, 2012 AORT Sale $16,020 +8.3%−5.5%−0.3%
June 5, 2012June 1, 2012 AORT Sale $13,710 not yetnot yetnot yet
February 22, 2012February 21, 2012 AORT Sale $28,050 −12.2%+1.5%+2.9%
December 7, 2011December 6, 2011 AORT Sale $13,681 not yetnot yetnot yet
May 9, 2011May 5, 2011 AORT Sale $21,613 +9.9%−12.5%−9.6%
November 15, 2010November 12, 2010 AORT Sale $12,008 −22.8%−21.7%−24.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Ronald C Elkins traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.